<DOC>
	<DOCNO>NCT01338662</DOCNO>
	<brief_summary>The purpose study compare onset time severity dyskinesia amantadine Dopamine agonist initial treat group Parkinson ` disease .</brief_summary>
	<brief_title>Comparison Incidence Dyskinesia Parkinson ` Disease Who Were Treated With Amantadine Dopamine Agonist</brief_title>
	<detailed_description>1 . Dopamine agonist delay risk dyskinesia initiate treatment rather levodopa . Amantadine typical antidyskinetic drug . There data comparison risk dyskinesia amantadine dopamine agonist initiate treatment . 2 . Prospective , randomize , open label study compare onset time severity dyskinesia group randomize assigned order amantadine dopamine agonist</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Dyskinesias</mesh_term>
	<mesh_term>Amantadine</mesh_term>
	<mesh_term>Dopamine</mesh_term>
	<mesh_term>Dopamine Agents</mesh_term>
	<mesh_term>Dopamine Agonists</mesh_term>
	<criteria>30 &lt; age &lt; 60 IPD H &amp; Y &lt; 3 previous dopaminergic medication history dyskinesia Parkinson plus clinically significant unstable medical surgical condition</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Parkinson ` disease</keyword>
</DOC>